{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/67105af848726944170ab1fe/68e49cdcf1f51e6179d6f104?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Vanessa Almendro-Navarro: Baby KJ and The Promise of Custom Gene Editing","description":"<p>When a rare genetic mutation left baby KJ without any treatment options, scientists and regulators confronted a profound ethical question: should medicine move fast enough to save a single child? For geneticist Vanessa Almendro-Navarro, PhD, KJ’s case represented both an urgent humanitarian mission and a glimpse into the future of personalized medicine. In this interview, she explains how her team created a bespoke gene-editing therapy for KJ, what it reveals about the rise of one-patient medicines, and how unprecedented collaboration is reshaping the boundaries of science and ethics.</p><p><br></p><p>Produced and hosted by Jonathan D. Grinstein, PhD</p><p>Audio mixed and mastered by David Mosely</p><p>Brought to you by Inside Precision Medicine (SAGE Publishing)</p><p><br></p>","author_name":"Inside Precision Medicine"}